3,5-bis(3-hydroxybenzylidene)piperidin-4-one

ID: ALA2386416

Chembl Id: CHEMBL2386416

PubChem CID: 66554458

Max Phase: Preclinical

Molecular Formula: C19H17NO3

Molecular Weight: 307.35

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1/C(=C/c2cccc(O)c2)CNC/C1=C\c1cccc(O)c1

Standard InChI:  InChI=1S/C19H17NO3/c21-17-5-1-3-13(9-17)7-15-11-20-12-16(19(15)23)8-14-4-2-6-18(22)10-14/h1-10,20-22H,11-12H2/b15-7+,16-8+

Standard InChI Key:  VAQPUHTZPOQXOC-BGPOSVGRSA-N

Associated Targets(Human)

Caco-2 (12174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
B16 (5829 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 307.35Molecular Weight (Monoisotopic): 307.1208AlogP: 2.74#Rotatable Bonds: 2
Polar Surface Area: 69.56Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.09CX Basic pKa: 6.40CX LogP: 3.29CX LogD: 3.24
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.75Np Likeness Score: 0.16

References

1. Gregory M, Dandavati A, Lee M, Tzou S, Savagian M, Brien KA, Satam V, Patil P, Lee M.  (2013)  Synthesis, cytotoxicity, and structureactivity insight of NH- and N-methyl-3,5-bis-(arylidenyl)-4-piperidones,  22  (11): [10.1007/s00044-013-0557-9]
2. Wu J, Zhang Y, Cai Y, Wang J, Weng B, Tang Q, Chen X, Pan Z, Liang G, Yang S..  (2013)  Discovery and evaluation of piperid-4-one-containing mono-carbonyl analogs of curcumin as anti-inflammatory agents.,  21  (11): [PMID:23611769] [10.1016/j.bmc.2013.03.057]
3. Tan KL, Ali A, Du Y, Fu H, Jin HX, Chin TM, Khan M, Go ML..  (2014)  Synthesis and evaluation of bisbenzylidenedioxotetrahydrothiopranones as activators of endoplasmic reticulum (ER) stress signaling pathways and apoptotic cell death in acute promyelocytic leukemic cells.,  57  (14): [PMID:24960549] [10.1021/jm401352a]
4. Singh RS, Michel D, Das U, Dimmock JR, Alcorn J..  (2014)  Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers.,  24  (22): [PMID:25442312] [10.1016/j.bmcl.2014.09.074]
5. Moreira J, Saraiva L, Pinto MM, Cidade H..  (2020)  Diarylpentanoids with antitumor activity: A critical review of structure-activity relationship studies.,  192  [PMID:32172081] [10.1016/j.ejmech.2020.112177]

Source